Brugada Syndrome: Management and Anaesthetic Implications: A Case ReportNuria Esteve*, Vicente Cuquerella, Marta Resalt and Ana Perez
Department of Anesthesia, General University Hospital of Elche, Alicante, Spain
- *Corresponding Author:
- Nuria Esteve
Department of Anesthesia
General University Hospital of Elche, Alicante
Received date: January 08, 2017; Accepted date: February 21, 2017; Published date: February 25, 2017
Citation: Esteve N, Cuquerella V, Resalt M, Perez A (2017) Brugada Syndrome: Management and Anaesthetic Implications: A Case Report. J Clin Case Rep 7: 927. doi: 10.4172/2165-7920.1000927
Copyright: © 2017 Esteve N, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Brugada syndrome (BrS) is a genetically determined disorder and has an autosomal dominant pattern of transmission, with incomplete penetrance and variable expression. These alterations may predispose to the development of reentrant arrhythmias, and therefore cause ventricular tachycardia and ventricular fibrillation. Patients may be asymptomatic, but they are prone to develop ventricular tachycardia or ventricular fibrillation and sudden death. Many events that occur during general anesthesia, such as drugs, temperature changes, and heart rate variations, may precipitate lethal arrhythmias in these patients. Thus, an individual anesthetic plan, taking into consideration the drugs that may induce arrhythmias, must be arranged before the surgery. Furthermore, it is essential to provide an exhaustive monitoring during the entire perioperative period. We describe a case of general anesthesia in a patient with Brugada syndrome who was diagnosed with right colon neoplasia and programmed for scheduled right hemicolectomy by laparotomy.